1- ( piperidin-4-yl) -pyrazole derivatives as GPR 119 modulators

Details for Australian Patent Application No. 2010255422 (hide)

Owner Pfizer Inc.

Inventors Mascitti, Vincent; McClure, Kim Francis; Munchhof, Michael John; Robinson Jr., Ralph Pelton; Deninno, Michael Paul; Futatsugi, Kentaro; Wei-Shung Kung, Daniel; Lefker, Bruce Allen

Agent Shelston IP

Pub. Number AU-A-2010255422

PCT Pub. Number WO2010/140092

Priority 61/184,355 05.06.09 US; 61/257,621 03.11.09 US

Filing date 27 May 2010

Wipo publication date 9 December 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/140092 Priority application(s): WO2010/140092

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010255430-Dynamically configuring attributes of a parent circuit on a network element

2010255407-Process and installation for making protected catalyst bodies by means of a molten organic substance